# A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece

> **NCT01086033** · — · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 566 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01086033
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 566 (ACTUAL)
- **Last updated:** 2013-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01086033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01086033, "A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01086033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*